Inactive

Modification SPE2D219D0066 P000010 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. SPE2D2-19-D-0066 P00009 National Drug Code (NDC) change for Omeprazole... Modification SPE2D219D0066 P000010 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. SPE2D2-19-D-0066 P00009 National Drug Code (NDC) change for Omeprazole Capsules 40MG in 30, 90, 100 and 500 count bottles only. Modification SPE2D2-19-D-0066 P00008 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. SPE2D2-19-D-0066 P00007 Manufacturer change for Omeprazole Capsules 20MG 90, 100 and 1000 count bottles only. SPE2D2-19-D-0066 P00006 to invoke Option year 4 effective October 26, 2022 through October 25, 2023. SPE2D2-19-D-0066 P00005 to invoke Option year 3 effective October 26, 2021 through October 25, 2022. OMEPRAZOLE